Technical Analysis for ARVN - Arvinas, Inc.

Grade Last Price % Change Price Change
D 42.60 -5.02% -2.25
ARVN closed down 5.02 percent on Monday, March 18, 2024, on 1.13 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.02%
Pocket Pivot Bullish Swing Setup -5.02%
Bollinger Band Squeeze Range Contraction -5.02%

   Recent Intraday Alerts

Alert Time
Down 5% about 13 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Lower Bollinger Band Support about 16 hours ago
Down 3% about 17 hours ago
Fell Below Lower Bollinger Band about 17 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera

Is ARVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 53.08
52 Week Low 13.57
Average Volume 766,253
200-Day Moving Average 29.50
50-Day Moving Average 44.09
20-Day Moving Average 46.57
10-Day Moving Average 45.70
Average True Range 2.58
RSI (14) 40.12
ADX 21.83
+DI 15.96
-DI 19.69
Chandelier Exit (Long, 3 ATRs) 45.33
Chandelier Exit (Short, 3 ATRs) 50.15
Upper Bollinger Bands 49.80
Lower Bollinger Band 43.33
Percent B (%b) -0.11
BandWidth 13.89
MACD Line -0.15
MACD Signal Line 0.54
MACD Histogram -0.6823
Fundamentals Value
Market Cap 2.34 Billion
Num Shares 55 Million
EPS -5.52
Price-to-Earnings (P/E) Ratio -7.72
Price-to-Sales 17.22
Price-to-Book 6.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.55
Resistance 3 (R3) 46.92 45.97 45.89
Resistance 2 (R2) 45.97 44.97 45.79 45.67
Resistance 1 (R1) 44.29 44.35 43.82 43.92 45.45
Pivot Point 43.34 43.34 43.11 43.16 43.34
Support 1 (S1) 41.66 42.34 41.19 41.29 39.75
Support 2 (S2) 40.71 41.72 40.53 39.53
Support 3 (S3) 39.03 40.71 39.31
Support 4 (S4) 38.66